Gastric Residual Volume in Critically Ill Patients: A Dead Marker or Still Alive?. (February 2015)

• Record Type: Journal Article
• Authors: Elke, Gunnar; Felbinger, Thomas W.; Heyland, Daren K.
• Is Part Of: Nutrition in clinical practice. Volume 30:Number 1(2015:Feb.)
• Page Start: 59
• Page End: 71
• Publication Date: 2015-02
• Subjects: gastric residual volume -- pneumonia -- critical illness -- enteral nutrition -- gastrointestinal transit -- gastrointestinal motility -- ventilator associated pneumonia -- respiratory aspiration; Nutrition -- Periodicals; Diet therapy -- Periodicals; Artificial feeding -- Periodicals; 615.854
• DOI: 10.1177/0884533614562841
• Languages: English
• ISSNs: 0884-5336

Abstract

Early enteral nutrition (EN) is consistently recommended as first-line nutrition therapy in critically ill patients since it favorably alters outcome, providing both nutrition and nonnutrition benefits. However, critically ill patients receiving mechanical ventilation are at risk for regurgitation, pulmonary aspiration, and eventually ventilator-associated pneumonia (VAP). EN may increase these risks when gastrointestinal (GI) dysfunction is present. Gastric residual volume (GRV) is considered a surrogate parameter of GI dysfunction during the progression of enteral feeding in the early phase of critical illness and beyond. By monitoring GRV, clinicians may detect patients with delayed gastric emptying earlier and intervene with strategies that minimize or prevent VAP as one of the major risks of EN. The value of periodic GRV measurements with regard to risk reduction of VAP incidence has frequently been questioned in the past years. Increasing the GRV threshold before interrupting gastric feeding results in marginal increases in EN delivery. More recently, a large randomized clinical trial revealed that abandoning GRV monitoring did not negatively affect clinical outcomes (including VAP) in mechanically ventilated patients. The results have revived the discussion on the role of GRV monitoring in critically ill, mechanically ventilated patients receiving early EN. This review summarizes the most recent clinical evidence on the use of GRV monitoring in critically ill patients. Based on the clinical evidence, it discusses the pros and cons and further addresses whether GRV is a dead marker or still alive for the nutrition management of critically ill patients.